Search clinical trials for: HIV-1 infected patients

Total 149237 results

TaiMed Biologics Inc.

Recruiting

TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

HIV-1-infection

United States
Excision BioTherapeutics

Active, not recruiting

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

HIV-1-infection

United States
Excision BioTherapeutics

Enrolling by invitation

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

HIV-1-infection

United States
Gilead Sciences

Active, not recruiting

Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women

HIV-1-infection

South Africa
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) (DRIVE-SHIFT)

HIV-1 Infection
Gilead Sciences

Completed

Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF) (BIC-STaR)

HIV-1-infection

Israel
Johns Hopkins University

Withdrawn

Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)

Pregnancy | HIV-1-infection
Makerere University
University of Pittsburgh; University of Nebraska; University of Liverpool

Unknown

Darunavir and Rilpivirine Interactions With Levonorgestrel Implant (DRIVE-2)

Contraception | HIV-1-infection

Uganda
TaiMed Biologics Inc.
Bill and Melinda Gates Foundation; Aaron Diamond AIDS Research Center

Completed

Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers (TMB-108)

Prevention of Infection With HIV-1

United States
Professor Francois Venter
Merck Sharp & Dohme LLC; Africa Health Research Institute

Recruiting

A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy (Opti-DOR)

HIV-1-infection

South Africa
University of Aarhus
Aarhus University Hospital; The Alfred; The Peter Doherty Institute for Infection... and other collaborators

Recruiting

Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART (AMBER)

HIV-1-infection

Denmark
Fundacion Clinic per a la Recerca Biomedica

Active, not recruiting

Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

HIV-1-infection

Spain
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France

Completed

National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection (OPTIPRIM-2)

HIV-1 Infection

France
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; MicroGeneSys Inc (nka Protein Sciences Corporation)

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

HIV Infections

United States, Puerto Rico
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Institut d'Investigació Biomèdica de Bellvitge; Germans Trias i Pujol Hospital and other collaborators

Completed

Study to Assess the ART Impact on the Brain Outcomes. The ARBRE Study (ARBRE)

Cognitive Impairment | HIV-1 Infection
Medicines Development for Global Health
Imperial College London; Phillip T. and Susan M. Ragon Foundation

Terminated

A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People

HIV Infections

United Kingdom
Incyte Corporation

Completed

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

HIV Infections

United States
Viriom

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Hepatic Impairment | HIV-1-infection

Russian Federation
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women

HIV-1-infection | Antenatal Care

Malawi
University of Connecticut
National Institute of Mental Health (NIMH)

Completed

HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users (HINTS)

Risk Reduction | HIV-1 Infection
Johns Hopkins University
Genentech, Inc.; FDA Office of Orphan Products Development

Completed

Clinical Trial on Treatment of Intraventricular Hemorrhage (CLEAR IVH)

Intraventricular Hemorrhage

United States, Germany, Canada, United Kingdom
International Partnership for Microbicides, Inc.

Completed

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

HIV Infections

Belgium
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

HIV Infections | HIV

Canada, United States, Puerto Rico, Thailand, Australia, France, Belgium, United Kingdom, Germany, Italy, Austria, Mexico, Portugal, Switzerland, Denmark, Netherlands, Sweden
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

HIV Infection | Atherosclerosis

Netherlands
ANRS, Emerging Infectious Diseases
INSERM SC10-US19

Recruiting

Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load (SYNACTHIV)

HIV-1-infection, Subtype b

Belgium, France
University of North Carolina, Chapel Hill
Medical University of South Carolina; National Institute of Mental Health (NIMH) and other collaborators

Completed

AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial (AQ2)

HIV/AIDS | Medication Adherence | Hiv | Sexual Behavior | Sexually Transmitted Infections (Not HIV or Hepatitis)

United States
Helios Salud
ViiV Healthcare

Unknown

Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America

Hiv | HIV-1-infection

Argentina
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sitagliptin for Reducing Inflammation and Immune Activation

HIV-1 Infection

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Terminated

Probiotic Visbiome for Inflammation and Translocation in HIV Ι (PROOV IT I)

HIV-1 Infection

Canada
Holdsworth House Medical Practice

Completed

Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months (CVD)

Cardiovascular Disease | HIV-1 Infection

Australia
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Biocine

Completed

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

HIV Infections

United States
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (BRYOLAT)

HIV Infection

Spain
International Partnership for Microbicides, Inc.

Completed

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

HIV Infections

Belgium
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

HIV Infections

Spain
Baylor Research Institute
French National Agency for Research on AIDS and Viral Hepatitis

Completed

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

HIV

United States
ANRS, Emerging Infectious Diseases
ViiV Healthcare

Completed

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone (DOLUVOIR)

HIV-1 Infection

France
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

HIV-1 Infection

United States, France, Austria, Germany
Gilead Sciences

Completed

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

HIV Infections

United States
Weill Medical College of Cornell University
AdhereTech

Completed

HIV Adherence Bottle Intervention Trial (HABIT)

Adherence, Medication | HIV-1-infection
Montefiore Medical Center
Centers for Disease Control and Prevention

Completed

Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV

HIV-1-infection | Pre-exposure Prophylaxis

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Unknown

Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)

HIV-1 Infection

Canada
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Completed

Towards HIV Functional Cure (ULTRASTOP)

Chronic HIV-1 Infection

France
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

HIV-1 Infection

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

HIV-1 Infection

United States
Gilead Sciences

Completed

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

HIV Infections

United States
Thomas Jefferson University

Completed

Safety Study of Elvucitabine in HIV-1 Subjects

HIV Infections

United States
Gilead Sciences

Completed

Combination of Efavirenz and Truvada - COMET Study

HIV Infections
bioLytical Laboratories

Completed

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

HIV Infections

United States
Assistance Publique - Hôpitaux de Paris
CSL Behring

Completed

A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma (GENHIV)

HIV-1 Infection

France
Gilead Sciences

Completed

Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

HIV Infections | HIV

United States, Spain, Puerto Rico, Australia, Thailand, Brazil, France, Belgium, Canada, Dominican Republic, United Kingdom, Germany, Netherlands, Italy, Austria, Denmark, Mexico, Portugal, Switzerland

3

Subscribe